BIIB vs TMP · P/E 21, rev $9.89B vs P/E 7.5, rev $79.3M
Biogen Inc (BIIB) versus Tompkins Financial Corporation (TMP) — a side-by-side from cached financials, not a winner call.
Biogen Inc (BIIB) is a drug manufacturers - general company listed on NASDAQ.
Tompkins Financial Corporation (TMP) is a banks - regional company listed on AMEX.
Latest reported BIIB revenue for 2025-12-31 was $9.89B. Net income was $1.29B. Revenue was up 2.2% from 2024-12-31 to 2025-12-31. BIIB currently screens at market cap $29.33B and trailing P/E 21.4.
Latest reported TMP revenue for 2024-12-31 was $79.3M. Net income was $71.0M. Revenue was up 5.7% from 2023-12-31 to 2024-12-31. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
BIIB currently screens at market cap $29.33B and trailing P/E 21.4. TMP currently screens at market cap $1.26B and trailing P/E 7.5.
Not investment advice. Open the BIIB and TMP stock pages for the full models.
Not investment advice.